Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

• Status: Completed
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Dissatisfaction with eyelash prominence,

• Eyelash prominence assessment of minimal or moderate,

• Ability to provide written informed consent

Exclusion Criteria:

• Subjects without visible lashes,

• Asymmetrical (uneven lashes or longer on one side than the other) eyelashes,

• Any eye disease or abnormality,

• Eye surgery,

• Permanent eyeliner,

• Eyelash implants,

• Eyelash extension application,

• Any use of eyelash growth products within 6 months of study entry,

• Treatments that may effect hair growth,

• Subjects requiring eye drop medications for glaucoma,

• Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.